1887

Access Microbiology open research platform logo

Volume 4, Issue 2

Prevalence and resistance pattern of uropathogens from community settings of different regions: an experience from India Open Access

Abstract

Urinary tract infection (UTI) is one of the most common infections in clinical practice worldwide in both healthcare and community settings causing significant morbidity and mortality. It is one of the major conditions at the community level treated empirically and regarded as a potential cause of emergence of antimicrobial resistance (AMR). Limited information is available regarding community-acquired UTI (CA-UTI) from India.

This is a first of its kind, multicentric-cross-sectional study at the community level targeting patients attending the out-patient department (OPD) of the community health centre (CHC) from four geographical regions (North, South, West and East) of India. The study had been designed to determine the epidemiology, antibiogram profile and identification of extended-spectrum beta-lactamase (ESBL) producer and carbapenem resistant (CR) uropathogens. Samples were collected prospectively from UTI suspected patients coming at CHC and processed at the tertiary healthcare centres using a common standard operating procedure. Clinical history of all the patients exhibiting significant bacteriuria was collected and data was analysed.

Overall, 250 out of a total of 2459 (10.1 %) urine samples were positive for bacteria with significant bacteriuria (adult: paediatrics, 6.7 : 1). Females were predominantly affected (male: female, 1 : 2.9). History of recent episode of UTI was observed as the commonest risk factor followed by diabetes mellitus. Altogether, 86 % of total cases were caused by (68 %) and (17.6 %) together. Among the commonly used oral antibiotics for the Gram-negative bacilli (GNB), the highest resistance was observed against beta-lactams, first- and second-generation cephalosporins, fluoroquinolones and co-trimoxazole. Overall, the prevalence of ESBL producer and CR isolates were 44.8, and 4.3 %, respectively. However, the ESBL production, CR and nitrofurantoin resistance among the uropathogenic (UPEC) isolates was 52.8, 5.1 and 14 %, respectively. No resistance was found against fosfomycin among the UPEC isolates.

The current study highlights the increasing incidence of AMR among uropathogens at the community-settings of India. A significant percentage of ESBL producers among the isolated UPEC and were observed. The currently available evidence supports the clinical recommendation of fosfomycin and nitrofurantoin for empiric therapy in CA-UTI in India.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): antimicrobial resistance , community-acquired urinary tract infection , India , Klebsiella pneumoniae , urinary tract infection and uropathogenic E. coli
© 2022 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/acmi/10.1099/acmi.0.000321
2022-02-09
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/acmi/4/2/acmi000321.html?itemId=/content/journal/acmi/10.1099/acmi.0.000321&mimeType=html&fmt=ahah

References

  1. Schmiemann G, Kniehl E, Gebhardt K, Matejczyk MM, Hummers-Pradier E. The diagnosis of urinary tract infection: a systematic review. Dtsch Arztebl Int 2010; 107:361–367 [View Article] [PubMed]
     [Google Scholar]
  2. Alós JI. Epidemiología y etiología de la infección urinaria comunitaria. Sensibilidad antimicrobiana de los principales patógenos y significado clínico de la resistencia. Enfermedades Infecciosas y Microbiología Clínica 2005; 23:3–8
     [Google Scholar]
  3. Kolawole AS, Kolawole OM, Kandaki-Olukemi YT, Babatunde SK, Durowade K et al. Prevalence of urinary tract infections (utiuti) among patients attending dalhatu araf specialist hospital, llafia, nnasarawa state, nnigeria. Int J Med Sciences 2009; 1:163–167
     [Google Scholar]
  4. Hooton TM. Uncomplicated urinary tract infection. N Engl J Med 2012; 366:1028–1037 [View Article] [PubMed]
     [Google Scholar]
  5. Grabe M, Bjerklund-Johansen TE, Botto H et al. European association of urology. Guidelines on Urological Infections 2015
     [Google Scholar]
  6. Nicolle LE. Urinary tract infections in special populations: diabetes, renal transplant, HIV infection, and spinal cord injury. Infect Dis Clin North Am 2014; 28:91–104 [View Article] [PubMed]
     [Google Scholar]
  7. Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG et al. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother 2006; 57:780–783 [View Article] [PubMed]
     [Google Scholar]
  8. Borah VV, Saikia KK, Chandra P, Hazarika NK, Chakravarty R. New Delhi metallo-β-lactamase and extended spectrum β-lactamases co-producing isolates are high in community-acquired urinary infections in Assam as detected by a novel multiplex polymerase chain reaction assay. Indian J Med Microbiol 2016; 34:173–182 [View Article] [PubMed]
     [Google Scholar]
  9. Saha S, Nayak S, Bhattacharyya I, Saha S, Mandal AK et al. Understanding the patterns of antibiotic susceptibility of bacteria causing urinary tract infection in West Bengal, India. Front Microbiol 2014; 5:1–7 [View Article] [PubMed]
     [Google Scholar]
  10. Shaikh S, Arora S, Pandya H. A 4-year study of community acquired urinary tract infections from a tertiary diagnostic centre in mumbai with special reference to MIC values. J Kidney 2018; 04:04 [View Article]
     [Google Scholar]
  11. Kumar MS, Das AP. Emerging nanotechnology based strategies for diagnosis and therapeutics of urinary tract infections: A review. Adv Colloid Interface Sci 2017; 249:53–65 [View Article] [PubMed]
     [Google Scholar]
  12. Tsuchida S, Umemura H, Nakayama T. Current Status of Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF MS) in clinical diagnostic microbiology. Molecules 2020; 25:4775 [View Article] [PubMed]
     [Google Scholar]
  13. CLSI M100S-S26 Performance Standards for Antimicrobial Susceptibility Testing 2016 p 26
     [Google Scholar]
  14. Kang CI, Kim J, Park DW, Kim BN, Ha US et al. Clinical practice guidelines for the antibiotic treatment of community-acquired urinary tract infections. Infect Chemother 2018; 50:67–100 [View Article] [PubMed]
     [Google Scholar]
  15. Fatima S, Muhammad IN, Usman S, Jamil S, Khan MN et al. Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients. Indian J Pharmacol 2018; 50:69–74 [View Article] [PubMed]
     [Google Scholar]
  16. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52:e103–20 [View Article] [PubMed]
     [Google Scholar]
  17. Sharma I, Paul D. Prevalence of community acquired urinary tract infections in Silchar Medical College, Assam, India and its antimicrobial susceptibility profile. Indian J Med Sci 2012; 66:273–279 [View Article] [PubMed]
     [Google Scholar]
  18. Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007; 6:1–7 [View Article] [PubMed]
     [Google Scholar]
  19. Tada DG, Gandhi PJ, Patel KN. A study on antibiotic related resistance in UTI patients: a comparison between community acquired and hospital acquired E. coli. National Journal of Community Medicine 2012; 3:255–258
     [Google Scholar]
  20. Gupta S, Kapur S, Padmavathi DV. Comparative prevalence of antimicrobial resistance in community-acquired urinary tract infection cases from representative States of northern and southern India. J Clin Diagn Res 2014; 8:DC09–12 [View Article] [PubMed]
     [Google Scholar]
  21. Hayami H, Takahashi S, Ishikawa K, Yasuda M, Yamamoto S et al. Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus. J Infect Chemother 2013; 19:393–403 [View Article] [PubMed]
     [Google Scholar]
  22. Harrison JW, Svec TA. The beginning of the end of the antibiotic era? part I. the problem: abuse of the “miracle drugs. Quintessence Int 1998; 3:151–162
     [Google Scholar]
  23. Yang B, Yang F, Wang S, Wang Q, Liu Z et al. Analysis of the spectrum and antibiotic resistance of uropathogens in outpatients at a tertiary hospital. J Chemother 2018; 30:145–149 [View Article] [PubMed]
     [Google Scholar]
  24. Seo M-R, Kim S-J, Kim Y, Kim J, Choi TY et al. Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea. J Korean Med Sci 2014; 29:1178–1181 [View Article] [PubMed]
     [Google Scholar]
  25. Prasada S, Bhat A, Bhat S, Shenoy Mulki S, Tulasidas S. Changing antibiotic susceptibility pattern in uropathogenic Escherichia coli over a period of 5 years in a tertiary care center. Infect Drug Resist 2019; 12:1439–1443 [View Article] [PubMed]
     [Google Scholar]
  26. Jia P, Zhu Y, Li X, Kudinha T, Yang Y et al. High prevalence of extended-spectrum beta-lactamases in Escherichia coli strains collected from strictly defined community-acquired urinary tract infections in adults in china: a multicenter prospective clinical microbiological and molecular study. Front Microbiol 2021; 12:1–12 [View Article] [PubMed]
     [Google Scholar]
  27. Tenover FC. Mechanisms of antimicrobial resistance in bacteria. Am J Infect Control 2006; 34:S3–10 [View Article] [PubMed]
     [Google Scholar]
  28. Bonkat G, Pickard R, Bartoletti R, Bruyère F, Geerlings SE et al. Guidelines on urological infections. In EAU Annual Congress Milan Italy: EAU Guidelines Office; 2017
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/acmi/10.1099/acmi.0.000321
Loading
Prevalence and resistance pattern of uropathogens from community settings of different regions: an experience from India
Access Microbiology 4, 000321 (2022); https://doi.org/10.1099/acmi.0.000321
/content/journal/acmi/10.1099/acmi.0.000321
/content/journal/acmi/10.1099/acmi.0.000321
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error